Results 1 to 10 of about 813,215 (250)

The Application of Nitric Oxide for Ocular Hypertension Treatment

open access: yesMolecules, 2021
Despite of various therapeutic methods for treating ocular hypertension and glaucoma, it still remains the leading cause of irreversible blindness. Intraocular pressure (IOP) lowering is the most effective way to slow disease progression and prevent ...
Binze Han   +4 more
doaj   +2 more sources

Malignant Hypertension: Ocular Manifestations [PDF]

open access: yesThe Scientific World Journal, 2006
Malignant hypertension may be the first manifestation of systemic hypertension. We report a clinical case of a Caucasian 41-year-old man with no previous history of blood hypertension seen at casualty because of blurred vision.
Silvia Muñoz   +2 more
doaj   +3 more sources

Intraocular pressure modifications in patients with acute central/hemicentral retinal vein occlusions [PDF]

open access: yesInternational Journal of Ophthalmology, 2021
Intraocular pressure (IOP) modifications in patients with acute central/hemicentral retinal vein occlusions (RVOs) consist in IOP reductions and increases.
Dan Calugaru, Mihai Calugaru
doaj   +1 more source

Ocular hypertension.

open access: yesIndian Journal of Ophthalmology, 2004
Gopal KS
doaj   +1 more source

Relationship between intraocular pressure and parameters of obesity in ocular hypertension [PDF]

open access: yesInternational Journal of Ophthalmology, 2020
AIM: To evaluate the correlation between intraocular pressure (IOP) and various obesity-related health factors in patients with ocular hypertension in Korea. METHODS: A total of 40 850 subjects underwent age, sex, body weight, and height assessments and
Min Won Ahn   +3 more
doaj   +1 more source

Ocular hypertension and severe intraocular pressure elevation after posterior subtenon injection of triamcinolone acetonide for various diseases [PDF]

open access: yesInternational Journal of Ophthalmology, 2020
AIM: To evaluate and compare the incidences of ocular hypertension and severe intraocular pressure (IOP) elevation after posterior subtenon injection of triamcinolone acetonide (PSTA) for various diseases.
Yun-Hsiang Yang   +3 more
doaj   +1 more source

Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis

open access: yeseLife, 2021
Glucocorticoids are widely used as an ophthalmic medication. A common, sight-threatening adverse event of glucocorticoid usage is ocular hypertension, caused by dysfunction of the conventional outflow pathway.
Guorong Li   +16 more
doaj   +1 more source

Delaying Treatment of Ocular Hypertension [PDF]

open access: yesArchives of Ophthalmology, 2010
To compare the safety and efficacy of earlier vs later treatment in preventing primary open-angle glaucoma (POAG) in individuals with ocular hypertension.One thousand six hundred thirty-six individuals with intraocular pressure (IOP) from 24 to 32 mm Hg in 1 eye and 21 to 32 mm Hg in the fellow eye were randomized to observation or to topical ocular ...
Michael A, Kass   +9 more
openaire   +2 more sources

Bevacizumab and Panretinal photocoagulation protect against ocular hypertension after posterior subtenon injection of triamcinolone acetonide for diabetic macular edema

open access: yesJournal of the Formosan Medical Association, 2017
To analyze the prognostic factors for ocular hypertension after posterior subtenon injection of triamcinolone acetonide (PSTA) for the treatment of diabetic macular edema (DME).
Yi-Ting Hsieh   +2 more
doaj   +1 more source

Membrane trophic effect of hyperglycemia on the anterior chamber angle tissues in ocular hypertension

open access: yesJournal of Ophthalmology, 2016
Introduction. Although there is a significant progress in the treatment of diabetic ocular complications, the issue of prevention and therapy for this pathology is still unstudied.
V.R. Yurevich
doaj   +1 more source

Home - About - Disclaimer - Privacy